What We’re Reading: Greenwald Out of The Intercept, Collaborating on Pandemic Data, and Bellingcat’s Updated Toolkit

For this week’s Friday 5, where GIJN rounds up interesting journalism news in English from around the world, we read about Glenn Greenwald’s resignation from The Intercept, a data journalism collaboration on COVID-19 data which reaches across eight newsrooms, and Bellingcat’s already excellent, and now updated, Online Investigation Toolkit.

Secrets to Searching for Video Footage

Verifying videos is important, but first you have to find them. This Bellingcat guide will provide advice and some tips on how to gather as much video as possible on a particular event, whether it is videos from witnesses of a natural disaster or a terrorist attack.

C чего начать расследование COVID-19: советы экспертов

История о коронавирусе – вероятно, самая главная история 2020 года, и будет ею ещё много лет. На что обратить внимание, рассказывая о здравоохранении или науке, об обществе, политике и экономике в эпоху пандемии – советуют всемирно известные журналисты.

What We’re Reading: WhatsApp Engagement, Media Survival, and Russian Disinformation

This week’s Friday 5, where we round up our favorite reads from around the online world in English, includes a Bellingcat post on what to look out for when reporting on Russian disinformation, how Documented is using WhatsApp to maximize reporting and audience reach, and the Oxford research group’s global effort to gather publicly available data on the coronavirus.

What We’re Reading: Tools for Investigating Coronavirus Fakes and Disinformation

This week’s Friday 5, where we round up our favorite reads from around the online world in English, includes tool from Bellingcat on investigating mis/disinformation during the pandemic, the Journalist’s Resource on what you need to know about referencing biomedical research preprints, and Oxford’s new Government Response Tracker, a project which is is collecting and aggregating publicly available data on government responses to COVID-19.